{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:47:59Z","timestamp":1782366479706,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jgar.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T13:00:13Z","timestamp":1522155613000},"page":"141-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia"],"prefix":"10.1016","volume":"14","author":[{"given":"Jesus","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Concha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Salavert-Llet\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Frasquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Castellanos-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.03.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01044-14","article-title":"Origin and evolution of European community-acquired methicillin-resistant Staphylococcus aureus","volume":"5","author":"Stegger","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.jgar.2018.03.007_bib0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections","volume":"54","author":"Van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.03.007_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.03.007_bib0020","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2018.03.007_bib0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.03.007_bib0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2018.03.007_bib0035","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1093\/jac\/dkv133","article-title":"Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?","volume":"70","author":"L\u00f3pez-Cort\u00e9s","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/jac\/dku487","article-title":"Relationship between consumption of MRSA-active antibiotics and burden of MRSA in acute care hospitals in Catalonia, Spain","volume":"70","author":"Grau","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.03.007_bib0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijmm.2013.04.004","article-title":"Antibiotic consumption and resistance: data from Europe and Germany","volume":"303","author":"Meyer","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.jgar.2018.03.007_bib0050","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1469-0691.2008.02026.x","article-title":"The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital","volume":"14","author":"Kritsotakis","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.03.007_bib0055","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","author":"Lodise","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.03.007_bib0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2018.03.007_bib0065","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3201\/eid1706.101037","article-title":"High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia","volume":"17","author":"Aguado","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2018.03.007_bib0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2018.03.007_bib0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijantimicag.2006.05.030","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus","volume":"28","author":"Kaatz","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.03.007_bib0080","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.03.007_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/21505594.2015.1011532","article-title":"Impact of daptomycin resistance on Staphylococcus aureus virulence","volume":"6","author":"Cameron","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2018.03.007_bib0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A current perspective on daptomycin for the clinical microbiologist","volume":"26","author":"Humphries","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2018.03.007_bib0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jgar.2018.03.007_bib0100","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/cid\/civ583","article-title":"Intra- and interinstitutional evaluation of an Etest for vancomycin minimum inhibitory concentration measurement in Staphylococcus aureus blood isolates","volume":"61","author":"Falc\u00f3n","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518300596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:52:48Z","timestamp":1761990768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518300596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":20,"alternative-id":["S2213716518300596"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.03.007","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin and daptomycin minimum inhibitory concentrations as a predictor of outcome of methicillin-resistant Staphylococcus aureus bacteraemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}